Clinical Trials Update:&nbsp;Jan. 4, 2005
4422
(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:
693379
questions over testing of a key HIV/AIDS drug before a US-backed roll-out of the treatment across the continent. Ingelheim to hide adverse effects of nevirapine when used to try to prevent mother-to-child HIV transmission.
466191
roundup Plus: .Mac customers suffer e-mail glitches...Alvarion expands wireless broadband in China...IBM launches business research group.
367540
WEDNESDAY, Dec. 8 (HealthDayNews) -- Two separate studies offer some good news about two drugs for the treatment of Parkinson's disease.
621066
Two newly published studies in the September 17, 2004 issue of Science give rise to the possibility of developing drug therapies that target eosinophils, white blood cells long known to be associated with the asthma.
589264
Panacos releases more clinical trial results for an exciting drug.
52664
MONDAY, Oct. 18 (HealthDayNews) --The National Institute on Aging has launched a landmark study aimed at finding a way to use imaging technology to reduce the time and cost of clinical trials for Alzheimer's disease medications.
417456
roundup Plus: .Mac customers suffer e-mail glitches...IBM launches business research group...Verbatim to make discs with HP labeling feature.
583563
a widely prescribed arthritis treatment - more than doubled patients&#39; risk of heart problems in a clinical study. The announcement, 11 weeks after Merck &amp; Co.
73400
Research and Markets (http://www.researchandmarkets.com/reports/c49927)  announces the addition of Frost & Sullivan's  new report Advances in Biomaterials for Medical Device Applications to  their offering.
5466
MONDAY, Sept. 10 (HealthDay News) -- Little more than one in eight phase II cancer clinical trials with encouraging results go forward to the larger, phase III stage that&#39;s needed to bring a new therapy to patients, a new study finds.
266395
New publications, experiments and breakthroughs in biotechnology--and what they mean.
734839
Neurocrine resubmits a marketing application for its lead drug.
383170
Human Genome Sciences, Inc. announced today that it has begun dosing patients in a Phase 2 clinical trial of HGS-ETR1 (agonistic human monoclonal antibody to TRAIL Receptor 1) in patients with advanced ...
208400
A late-stage trial of Nexavar in patients with nonsmall-cell lung cancer after a committee said it would not meet the main goal of improving overall survival.
25097
The risk of treatment-related (toxic) death for cancer patients enrolled in phase 1 clinical trials had decreased significantly over the past 12 years (from 1991 to 2002), according to an article in the November 3 issue of JAMA.
197909
roundup Plus: IBM gives grants to universities...Sun expands pay-as-you go supercomputing...SGI works on Linux performance software.